Cathay Pacific Shares in Focus as Air China Plans Major Stake Reduction 
Embraer Boosts Aircraft Deliveries in Q4 2025, Signaling Strong Growth Into 2026 
Newmont Goldcorp Expects Lower Q1 2026 Gold Output After Western Australia Bushfire 
Nvidia Unveils Rubin Platform to Power Next Wave of AI Infrastructure 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Tesla UK Sales Slide as Competition Intensifies, While BYD Surges in Electric Vehicle Market 
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
Barclays Invests in Stablecoin Clearing Firm Ubyx to Advance Digital Money Strategy 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Lenovo Unveils AI Cloud Gigafactory With NVIDIA and Launches New AI Platform at CES 2026 
Dell Revives XPS Laptop Lineup With New XPS 14 and XPS 16 to Boost Premium PC Demand 
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs 
BTIG Initiates Buy on SoftBank as AI and Robotics Strategy Gains Momentum 
NEW YORK, April 04, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased DS Healthcare Group, Inc. (NASDAQ:DSKX) securities between August 13, 2015 and March 23, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/ds-healthcare-group. There is no cost or obligation to you.
On March 23, 2016, DS Healthcare revealed that its financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015 were found to have revenue recognition errors and improper recording of certain equity. The Company also announced that the Audit Committee and independent counsel had initiated an investigation in connection with the company’s President, Daniel Khesin, for allegedly fraudulent revenue recognition and equity transaction errors, and that Mr. Khesin had been dismissed. Then on March 28, 2016, the Company announced that the Audit Committee determined the errors totaled approximately $900,000 in reduced revenues, and that as a result, estimated unaudited 2015 fiscal year revenues should be reduced by approximately 6 percent.
If you suffered a loss in DS Healthcare you have until May 31, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/ds-healthcare-group.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
